revel x semaglutide RelivianceGLP1 Oral Semaglutide.png Novo's semaglutide reduced risk of

Ready to take the next step toward better health and performance

doi: 10.2147/JIR.S152835 51 Ibil BykcokunNGleGCam EtzBOzlkK

pmid:24805240 8

The trial involving more than 3500 participants with type 2 diabetes and chronic kidney disease from 28 countries including Australia, the USA and China found a small weekly dose of semaglutide reduced the risk of major kidney events by 24 per cent

98 KriegsteinA.Alvarez-BuyllaA

Thus, T2DM is associated with immunological dysregulation, which is potentially equivalent to accelerated ageing, and could therefore potentially explain the poor prognosis in patients with diabetes mellitus and COVID-19 (Fig